Protalix BioTherapeutics, Inc. Expense Breakdown
No Expense Breakdown for PLX on this site yet.
- 2025-12-31: Single Operating $996.00K.
- 2024-12-31: Single Operating $1.22M.
- 2023-12-31: Single Operating $254.00K.
Source checked: the stored Expense Breakdown page for PLX.
Expenses by product
Income Tax Expense (Benefit): each year (12 month)
| Fiscal year end | Single Operating |
|---|---|
| 2025-12-31 | $996.00K |
| 2024-12-31 | $1.22M |
| 2023-12-31 | $254.00K |
Income Tax Expense (Benefit): each quarter (3 month)
| Quarter end | Single Operating | Single Reportable |
|---|---|---|
| 2026-06-30 | $1.08M | |
| 2026-03-31 | $2.82M | |
| 2025-06-30 | $497.00K | |
| 2025-03-31 | -$113.00K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |